09/08/2020
3:09 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2020
3:24 PM | Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2020
9:25 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2020
6:17 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2020
6:04 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2020
4:14 PM | Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
4:14 PM | Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
4:14 PM | Agios Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
4:13 PM | Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
4:13 PM | Agios Pharmaceuticals (Issuer)
CLARK IAN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/30/2020
6:19 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2020
3:18 PM | Agios Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
3:02 PM | Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
3:55 PM | Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
3:53 PM | Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
3:52 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
3:51 PM | Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
3:50 PM | Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
3:05 PM | Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
3:21 PM | Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
6:40 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2020
6:23 AM | Agios Pharmaceuticals (Subject)
VANGUARD SPECIALIZED FUNDS (Filed by)
| Form SC 13G/A
| |
01/13/2020
3:32 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
5:43 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2020
3:24 PM | Agios Pharmaceuticals (Issuer)
Car Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2020
3:19 PM | Agios Pharmaceuticals (Issuer)
Car Bruce (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2020
1:01 PM | Agios Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
12/30/2019
3:08 PM | Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2019
3:02 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2019
3:07 PM | Agios Pharmaceuticals (Issuer)
Biller Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2019
3:02 PM | Agios Pharmaceuticals (Issuer)
Biller Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/22/2019
4:01 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2019
3:06 PM | Agios Pharmaceuticals (Issuer)
Celgene Alpine Investment Co., LLC (Reporting)
CELGENE CORP /DE/ (Reporting)
Celgene European Investment Co LLC (Reporting)
Celgene Switzerland LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2019
4:03 PM | Agios Pharmaceuticals (Filer)
| Form 424B5
| |
11/08/2019
3:57 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2019
4:09 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2019
8:14 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2019
6:39 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2019
6:20 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2019
3:20 PM | Agios Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A
| |
09/30/2019
10:13 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2019
4:05 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2019
7:56 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2019
6:29 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2019
11:41 AM | Agios Pharmaceuticals (Filer)
| Form CT ORDER
| |
06/13/2019
3:07 PM | Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2019
3:08 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2019
3:02 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2019
3:08 PM | Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:08 PM | Agios Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:07 PM | Agios Pharmaceuticals (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:05 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:05 PM | Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:04 PM | Agios Pharmaceuticals (Issuer)
CLARK IAN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:03 PM | Agios Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2019
3:13 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2019
2:24 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2019
7:57 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2019
6:24 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2019
10:46 AM | Agios Pharmaceuticals (Filer)
| Form CT ORDER
| |
04/26/2019
10:06 AM | Agios Pharmaceuticals (Filer)
| Form CT ORDER
| |
04/24/2019
4:38 PM | Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2019
3:07 PM | Agios Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/18/2019
3:04 PM | Agios Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/09/2019
3:59 PM | Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2019
3:25 PM | Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2019
3:06 PM | Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
3:04 PM | Agios Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2019
3:27 PM | Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2019
3:25 PM | Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2019
3:24 PM | Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2019
3:21 PM | Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2019
3:02 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2019
3:03 PM | Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2019
3:05 PM | Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2019
3:04 PM | Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2019
3:03 PM | Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2019
3:01 PM | Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
8:07 AM | Agios Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2019
7:48 AM | Agios Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2019
6:16 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2019
10:18 AM | Agios Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/05/2019
3:28 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2019
9:09 AM | Agios Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A
| |
01/31/2019
2:03 PM | Agios Pharmaceuticals (Subject)
VANGUARD SPECIALIZED FUNDS (Filed by)
| Form SC 13G/A
| |
01/28/2019
3:01 PM | Agios Pharmaceuticals (Subject)
BB BIOTECH AG (Filed by)
| Form SC 13G/A
| |
01/23/2019
3:22 PM | Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2019
3:19 PM | Agios Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2019
3:12 PM | Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
6:48 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2018
3:39 PM | Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2018
3:30 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2018
3:03 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2018
3:01 PM | Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2018
3:01 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2018
3:09 PM | Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2018
3:12 PM | Agios Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
| Form 4/A
| |
11/01/2018
8:33 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2018
6:45 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2018
3:09 PM | Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
